抗胆碱药治疗COPD的研究进展

被引:11
作者
张倩
殷凯生
机构
[1] 南京医科大学第一附属医院呼吸科
关键词
慢性阻塞性肺疾病; 抗胆碱药; COPD;
D O I
暂无
中图分类号
R563.9 [其他];
学科分类号
摘要
慢性阻塞性肺疾病(COPD)是一组以不完全可逆的慢性气道阻塞为特征的疾病。其主要病理生理机制为迷走神经控制的高分泌和胆碱能机制透发的支气管平滑肌张力增加。药物治疗仍是目前COPD的主要治疗方法。而作为支气管舒张剂的抗胆碱药,由于其特殊的作用机理,已成为COPD的一线治疗药物,在COPD的治疗学中具有重要地位。
引用
收藏
页码:149 / 153
页数:5
相关论文
共 17 条
[1]  
Role of muscarinic receptor subtypes in the constriction of peripheral airway: studies on recep tor-deficient mice. Struckmann N,Schwering S,Wiegand S,et al. Molecular Pharmacology . 2003
[2]  
A long term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Casaburi R,Mahler DA,Jones PW,et al. European Respiratory Journal . 2002
[3]  
Economic burden of chronic obstructive pulmonary disease: Impact of new treatment options. Friedman M,Hilleman DE. Pharmacoeconomics . 2001
[4]  
Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Vincken W,van Noord JA,Grecfhorst AP,ef al. European Respiratory Journal . 2002
[5]  
The effects of oxitropium bromide on exercise performance in patients with chronic obstructive pulmonary disease. Oga T,Nishimura K,Tsukino M,et al. American Journal of Respiratory and Critical Care Medicine . 2000
[6]  
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Brusasco V,Hodder R,Miravitlles M,et al. Thorax . 2003
[7]  
Anticholinergics in the treatment of chronic obstructive pulmonary disease. Beeh KM,Welte T,Buhl R,et al. Respiration . 2002
[8]  
Long-term treatment benefit with tiotropium in COPD patients with and without short-term brochodilator responses. Tashkin D,Kesten S. Chest . 2003
[9]  
A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Oga T,Nishimura K,Tsukino M,et al. Chest . 2003
[10]  
A randomized controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. van Noord JA,Bantje TA,Eland ME,et al. Thorax . 2000